Health knowledge made personal

Mark Pool, MD

I practice general surgical pathology and serve as laboratory medical director at Riverside Medical Center in Kankakee, Illinois. I am also an adjunct attending at Rush Medical College in Chicago. My specialty challenges and humbles me because of the sublime variation and complexity of diseases... Full Bio
› Share page:

Posts

Sort by: Most recent | Name
In working up a malaria p ... by Mark Pool, MD Posted in: Blog Posts in Cancer In working up a malaria peripheral blood smear this morning, I came across an excellent website for parasite identification: http://www.dpd.cdc.gov/dpdx/default.htm ... Read on »
"Transfusion News" a new site launched by AABB and Ortho Clinical Diagnostics by Mark Pool, MD Posted in: Blog Posts in Cancer Check out this new web site for transfusion-related news. Excellent site design and content. AABB has partnered with Ortho Clinical Diagnostics to launch Transfusion News, a ... Read on »
1-Cancer microenvironment: the role of stroma in neoplasia (more USCAP 2010) by Mark Pool, MD Posted in: Blog Posts in Cancer This post is more from USCAP 2010.  I attended the "Advanced Molecular BIology" Special Course at USCAP on March 23.  One of the highlights was Dr. Rob West's presentat ... Read on »
A Consensus Statement of EGFR Mutation Testing in NSCLC by Mark Pool, MD Posted in: Blog Posts in Cancer The International Association for the Study of Lung Cancer (IASLC) and European Thoracic Oncology Platform recently published a consensus statement regarding EGFR mutat ... Read on »
A Reflection on My Practice of Pathology by Mark Pool, MD Posted in: Blog Posts in Cancer A few months ago, I received an email from a newly-minted pathologist/reader of this blog who was having an existential moment of angst questioning when the anxiety of ... Read on »
AABB Audioconferences for November: Hemorrhage in OB patients and cold agglutinins by Mark Pool, MD Posted in: Blog Posts in Cancer AABB will host two audioconferences next month of interest pathologists who manage blood transfusion services.  A Nov. 3 audioconference will look at hemorrhaging in ob ... Read on »
AABB SmartBrief: Mismatched cord blood transplants can be effective by Mark Pool, MD Posted in: Blog Posts in Cancer Studies: Mismatched cord blood, marrow transplants can be effective Results of transplants with unrelated umbilical cord blood or mismatched bone marrow were comparab ... Read on »
Aberrant Wnt1 and beta-catenin expression in NSCLC by Mark Pool, MD Posted in: Blog Posts in Cancer This month's April 2011 Journal of Thoracic Oncology has an interesting paper by Xu and colleagues ( abstract ) that examines Wnt1 expression in non-small cell lung can ... Read on »
Abstracts and Posters Accepted Now for Pathology Visions 2012 by Mark Pool, MD Posted in: Blog Posts in Cancer As a courtesy to the Digital Pathology Association, I am passing along this information regarding the 2012 Pathology Visions conference in Baltimore, Maryland from October 2 ... Read on »
Abstracts solicited for Pathology Informatics 2010 Conference by Mark Pool, MD Posted in: Blog Posts in Cancer Dr. Bruce Friedman at LabSoftNews blog has announced a call for abstracts for the Pathology Informatics 2010 Conference in Boston on September 19-22, 2010. The confe ... Read on »
Advanced DNA Robots by Mark Pool, MD Posted in: Blog Posts in Cancer Scientists Announce Advanced DNA Robots - WSJ.com I'm not sure what this directly has to do with my blog.  But I thought it was a really cool story.  I thought about ... Read on »
ALK -Positive Lung Adenocarcinoma: NEJM Case Records by Mark Pool, MD Posted in: Blog Posts in Cancer The July 14, 2011 issue of The New England Journal of Medicine features a nice case report as part of the weekly "Case Records of the MGH" series.  I thought those inte ... Read on »
ALK Inhibition in Non-Small Cell Lung Cancer and Inflammatory Myofibroblastic Tumor by Mark Pool, MD Posted in: Blog Posts in Cancer Great stuff in this week's NEJM! Today's (October 28, 2010) New England Journal of Medicine has no less than three articles reporting the use of small molecule AL ... Read on »
All the RAGE in Asthma by Mark Pool, MD Posted in: Blog Posts in Cancer My lab's CAP inspection is finally over!!! Now I can get back to more regular blogging (without guilt). This month's American Journal of Pathology features an intriguing art ... Read on »
Amazon's Kindle 2--future portable medical library? by Mark Pool, MD Posted in: Blog Posts in Cancer Walter Mossberg of the Wall Street Journal recently reviewed the wireless reading machine from Amazon called Kindle.  This is the second generation of this mach ... Read on »
Analyzing Malpractice Claims to Reduce Errors--a pathologist's perspective by Mark Pool, MD Posted in: Blog Posts in Cancer The Informed Patient column by Laura Landro from yesterday's Wall Street Journal (September 27, 2010) has an interesting report entitled, "What the Doctor Missed" whic ... Read on »
Apps & Smartphones in Medical Education by Mark Pool, MD Posted in: Blog Posts in Cancer Medical students across the country are coming into a day and age where technology rules, and in a society where iPads and Android phones are voted king, it is no small wond ... Read on »
ASCO 2009 Report--SLN micromets in breast cancer by Mark Pool, MD Posted in: Blog Posts in Cancer Results from the Dutch MIRROR (Micrometastases and Isolated Tumor Cells: Relevant and Robust or Rubbish?) study were presented last week at ASCO 2009 and showed ... Read on »
ASCO 2009--Herceptin in Gastric Cancer by Mark Pool, MD Posted in: Blog Posts in Cancer As a follow-up to my previous post on HER2 in gastric cancer, here is a summary of the new results from the ToGA trial presented at ASCO 2009 which have been ca ... Read on »
ASCO 2010: Erlotinib plus novel cMET inhibitor in NSCLC by Mark Pool, MD Posted in: Blog Posts in Cancer I was attending the 2010 ASCO Annual Meeting this past weekend, June 5-6, and will post some blogs about my "highlights."  This is a perk of living in Chicago since the ... Read on »